VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AIZNAssurant, Inc. 5.25% Subordinat
$18.90$939M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AIZN logoAssurant, Inc. 5.25% Subordinat(AIZN)Earnings, Financials & Key Ratios

AIZN•NYSE•Insurance & Managed Care
1.1× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryDiversified InsuranceSub-IndustryHousing and title insurers
AboutAssurant, Inc. engages in the provision of lifestyle and housing solutions for consumer purchases. It operates through the following segments: Global Lifestyle, Global Housing, and Corporate and Other. The Global Lifestyle segment offers mobile device solutions and extended service products and related services for mobile devices, consumer electronics and appliances, vehicle protection, and related services. The Global Housing segment includes lender-placed homeowners’ insurance, lender-placed manufactured housing insurance, lender-placed flood insurance, renters' insurance, and related products, voluntary manufactured housing insurance, voluntary homeowners’ insurance and other specialty products. The Corporate and Other segment refers to the corporate employee-related expenses and activities of the holding company. The company was founded in 1892 and is headquartered in Atlanta, GA.Show more
  • Revenue$12.81B+7.9%
  • Combined Ratio91.51%-0.7%
  • Net Income$873M+14.8%
  • Return on Equity15.9%+3.7%
  • Medical Cost Ratio22.85%-1.9%
  • Operating Margin8.49%+8.7%
  • Net Margin6.81%+6.4%
  • ROA2.45%+10.5%
  • Equity / Assets16.18%+11.0%

AIZN Key Insights

Assurant, Inc. 5.25% Subordinat (AIZN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Profitable underwriting: 91.5% combined ratio
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Low loss ratio of 22.8%
  • ✓Good 3Y average ROE of 15.1%
  • ✓Share count reduced 4.5% through buybacks
  • ✓Trading at only 0.2x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AIZN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AIZN Price & Volume

Assurant, Inc. 5.25% Subordinat (AIZN) stock price & volume — 10-year historical chart

Loading chart...

AIZN Growth Metrics

Assurant, Inc. 5.25% Subordinat (AIZN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.2%
5 Years5.92%
3 Years7.93%
TTM9.02%

Profit CAGR

10 Years19.95%
5 Years14.64%
3 Years46.67%
TTM49.19%

EPS CAGR

10 Years23.84%
5 Years21.02%
3 Years51.01%
TTM53.39%

Return on Capital

10 Years4.17%
5 Years6.78%
3 Years8.75%
Last Year9.27%

AIZN Recent Earnings

Assurant, Inc. 5.25% Subordinat (AIZN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/9 qtrs (100%)●Beat Revenue 4/9 qtrs (80%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$5.47+2.4%
$5.34
Rev
$3.4B+3.8%
$3.3B
Q1 2026
Feb 10, 2026
Metric
Actual
Est
EPS
$5.61+1.3%
$5.54
Rev
$3.4B+1.3%
$3.3B
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$5.18+18.0%
$4.39
Rev
$3.2B+1.4%
$3.2B
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$4.56+1.3%
$4.50
Rev
$3.2B+1.1%
$3.1B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$5.47vs $5.34+2.4%
$3.4Bvs $3.3B+3.8%
Q1 2026Feb 10, 2026
$5.61vs $5.54+1.3%
$3.4Bvs $3.3B+1.3%
Q4 2025Nov 4, 2025
$5.18vs $4.39+18.0%
$3.2Bvs $3.2B+1.4%
Q3 2025Aug 5, 2025
$4.56vs $4.50+1.3%
$3.2Bvs $3.1B+1.1%
Based on last 9 quarters of dataView full earnings history →

AIZN Peer Comparison

Assurant, Inc. 5.25% Subordinat (AIZN) competitors in Housing and title insurers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AIZ logoAIZAssurant, Inc.Direct Competitor12.94B259.8614.947.89%7.6%17.4%0.38
PRU logoPRUPrudential Financial, Inc.Direct Competitor37.05B106.5310.42-14.01%5.62%10.26%0.65
MET logoMETMetLife, Inc.Direct Competitor55.8B85.5817.8310.22%4.7%12.72%0.70
AFL logoAFLAflac IncorporatedDirect Competitor59.49B115.4716.91-8.84%21%13.05%0.29
UNM logoUNMUnum GroupDirect Competitor14.53B89.9821.022.07%5.87%7.07%0.35
CNO logoCNOCNO Financial Group, Inc.Direct Competitor4.76B50.8321.630.94%4.94%8.6%1.54
ESNT logoESNTEssent Group Ltd.Product Competitor5.39B58.458.47-0.49%53.34%12.01%0.09
NMIH logoNMIHNMI Holdings, Inc.Product Competitor2.85B37.487.628.39%55.07%15.8%0.16

Compare AIZN vs Peers

Assurant, Inc. 5.25% Subordinat (AIZN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AIZ

Most directly comparable listed peer for AIZN.

Scale Benchmark

vs AAPL

Larger-name benchmark to compare AIZN against a more recognizable public peer.

Peer Set

Compare Top 5

vs AIZ, PRU, MET, AFL

AIZN Income Statement

Assurant, Inc. 5.25% Subordinat (AIZN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue
6.31B8B9.53B9.61B10.19B10.19B11.13B11.88B12.81B13.16B
Revenue Growth %
-11.21%26.77%19.11%0.85%6%0.05%9.21%6.7%7.89%9.02%
Medical Costs & Claims
3.21B4.64B5.62B5.95B6.04B2.36B2.52B2.77B2.93B2.92B
Medical Cost Ratio %
50.87%58.04%59%61.88%59.27%23.15%22.65%23.29%22.85%22.17%
Gross Profit
3.1B▲ 0%
3.36B▲ 8.3%
3.91B▲ 16.4%
3.66B▼ 6.2%
4.15B▲ 13.3%
7.83B▲ 88.8%
8.61B▲ 9.9%
9.11B▲ 5.8%
9.89B▲ 8.5%
10.24B▲ 0%
Gross Margin %
49.13%41.96%41%38.12%40.73%76.85%77.35%76.71%77.15%77.83%
Gross Profit Growth %
-56.38%8.28%16.37%-6.24%13.28%88.76%9.91%5.82%8.51%-
Operating Expenses
2.66B3.02B3.45B3.09B3.38B7.48B7.8B8.18B8.8B9B
OpEx / Revenue %
42.08%37.79%36.23%32.1%33.16%73.42%70.1%68.9%68.67%68.42%
Depreciation & Amortization
115.7M126.9M125.5M142.3M171.6M182M196.4M223.5M250M193.3M
Combined Ratio %
92.96%95.83%95.23%93.98%92.43%96.57%92.75%92.19%91.51%90.58%
Operating Income
444.5M▲ 0%
333.5M▼ 25.0%
454.7M▲ 36.3%
578.1M▲ 27.1%
771.3M▲ 33.4%
349.9M▼ 54.6%
806.8M▲ 130.6%
927.3M▲ 14.9%
1.09B▲ 17.3%
1.24B▲ 0%
Operating Margin %
7.04%4.17%4.77%6.02%7.57%3.43%7.25%7.81%8.49%9.42%
Operating Income Growth %
-50.95%-24.97%36.34%27.14%33.42%-54.63%130.58%14.94%17.27%-
EBITDA
560.2M460.4M580.2M720.4M942.9M531.9M1B1.15B1.34B1.43B
EBITDA Margin %
8.88%5.75%6.09%7.5%9.26%5.22%9.01%9.69%10.44%10.89%
Interest Expense
49.5M100.3M110.6M104.5M111.8M108.3M108M107M109.7M111.2M
Non-Operating Income
-49.5M-100.3M-110.6M-104.5M-111.8M-108.3M-108M-107M-109.7M-111.2M
Pretax Income
444.5M▲ 0%
333.5M▼ 25.0%
454.7M▲ 36.3%
578.1M▲ 27.1%
771.3M▲ 33.4%
349.9M▼ 54.6%
806.8M▲ 130.6%
927.3M▲ 14.9%
1.09B▲ 17.3%
1.24B▲ 0%
Pretax Margin %
7.04%4.17%4.77%6.02%7.57%3.43%7.25%7.81%8.49%9.42%
Income Tax
-75.1M80.9M148.3M58.7M168.4M73.3M164.3M167.1M214.7M239.1M
Effective Tax Rate %
-16.9%24.26%32.61%10.15%21.83%20.95%20.36%18.02%19.74%19.29%
Net Income
519.6M▲ 0%
251M▼ 51.7%
382.6M▲ 52.4%
440.8M▲ 15.2%
1.36B▲ 208.9%
276.6M▼ 79.7%
642.5M▲ 132.3%
760.2M▲ 18.3%
872.7M▲ 14.8%
1B▲ 0%
Net Margin %
8.23%3.14%4.01%4.59%13.37%2.71%5.77%6.4%6.81%7.6%
Net Income Growth %
-8.09%-51.69%52.43%15.21%208.94%-79.69%132.28%18.32%14.8%49.19%
EPS (Diluted)
9.39▲ 0%
4.22▼ 55.1%
6.14▲ 45.5%
6.70▲ 9.1%
10.20▲ 52.2%
5.05▼ 50.5%
11.95▲ 136.6%
14.46▲ 21.0%
17.39▲ 20.3%
19.93▲ 0%
EPS Growth %
2.85%-55.06%45.5%9.12%52.24%-50.49%136.63%21%20.26%53.39%
EPS (Basic)
9.454.246.187.0410.375.0912.0214.5517.29-
Diluted Shares Outstanding
55.31M59.55M62.31M63.18M60.12M54.78M53.78M52.58M50.2M50.2M

AIZN Balance Sheet

Assurant, Inc. 5.25% Subordinat (AIZN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets
31.84B41.09B44.29B44.65B33.92B33.12B33.64B35.02B36.29B33.55B
Asset Growth %
7.18%29.04%7.79%0.81%-24.03%-2.37%1.56%4.12%3.62%5.96%
Total Investment Assets
12.3B15.09B16.59B8.22B8.67B7.52B8.22B8.54B10.06B4M
Long-Term Investments
11.06B13.69B15.13B7.4B1.21B1.09B6.11B1.09B7.34B33.28B
Short-Term Investments
9.95B11.63B12.72B7.11B7.46B6.44B2.11B7.46B2.72B8.78B
Total Current Assets
000017.69B17.47B12.75B19.03B13.15B12.4B
Cash & Equivalents
996.8M1.25B1.87B2.21B2.04B1.54B1.63B1.81B1.83B1.59B
Receivables
11.15B10.81B11.29B8.15B8.19B9.49B9.01B9.76B8.6B29.1B
Other Current Assets
-22.1B-23.69B-25.88B-17.47B000000
Goodwill & Intangibles
1.23B6.1B4.89B4.44B12.69B13.18B13.23B13.14B13.36B42.63B
Goodwill
917.7M2.32B2.34B2.59B2.57B2.6B2.61B2.62B2.65B2.65B
Intangible Assets
313M3.78B2.54B1.85B10.11B10.58B10.62B10.53B10.71B511.1M
PP&E (Net)
347.6M392.5M433.7M446.1M561.4M645.1M685.8M768.3M841.7M0
Other Assets
-12.64B-20.19B-20.46B-12.28B1.78B738.3M862.3M991.7M1.6B19.08B
Total Liabilities
27.56B35.96B38.61B38.7B28.46B28.89B28.83B29.91B30.42B29.9B
Total Debt
1.07B2.01B2.01B2.25B2.2B2.13B2.08B2.08B2.21B2.21B
Net Debt
71.4M752M139.8M45.3M161.7M593.2M453M275.4M372.8M615.8M
Long-Term Debt
1.07B2.01B2.01B2.25B2.2B1.91B2.08B2.08B2.21B2.21B
Short-Term Debt
00000224.7M0000
Total Current Liabilities
000021.73B23.74B23.47B23.96B23.89B0
Accounts Payable
3.93B3.14B3.05B1.97B2.05B2.7B2.42B2.91B2.1B0
Deferred Revenue
000018.62B19.8B20.11B20.21B20.88B20.9B
Other Current Liabilities
-4.29B-3.48B-3.59B-2.67B364.2M366.6M392.7M277.7M266.4M-20.9B
Deferred Taxes
0000000000
Other Liabilities
-1.2B-2.06B-2.01B-2.25B4.52B3.24B3.28B3.87B4.32B2.11B
Total Equity
4.28B▲ 0%
5.13B▲ 19.9%
5.68B▲ 10.7%
5.95B▲ 4.8%
5.46B▼ 8.2%
4.23B▼ 22.6%
4.81B▲ 13.7%
5.11B▲ 6.2%
5.87B▲ 15.0%
5.87B▲ 0%
Equity Growth %
4.48%19.91%10.68%4.8%-8.24%-22.61%13.73%6.18%14.98%46.56%
Shareholders Equity
4.27B5.11B5.65B5.95B5.46B4.23B4.81B5.11B5.87B5.87B
Minority Interest
10.9M21.9M29.3M3.4M000000
Retained Earnings
4.04B5.76B5.97B3.55B4.04B3.7B4.03B4.38B4.83B4.95B
Common Stock
1.5M1.6M1.6M600K700K600K600K500K500K6.5B
Accumulated OCI
234M-155.4M411.5M709.8M-150M-986.2M-765M-836.1M-544.2M-629M
Return on Equity (ROE)
12.4%5.33%7.07%7.58%23.85%5.71%14.22%15.33%15.9%17.4%
Return on Assets (ROA)
1.69%0.69%0.9%0.99%3.47%0.83%1.93%2.21%2.45%2.83%
Equity / Assets
13.45%12.49%12.83%13.34%16.11%12.77%14.3%14.58%16.18%17.5%
Debt / Equity
0.25x0.39x0.35x0.38x0.40x0.50x0.43x0.41x0.38x0.38x
Book Value per Share
77.4186.2291.1994.2590.8877.1989.4297.12116.97116.93
Tangible BV per Share
55.16-16.2612.7524.01-120.10-163.43-156.51-152.86-149.1053.86

AIZN Cash Flow Statement

Assurant, Inc. 5.25% Subordinat (AIZN) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
530.4M656.7M1.41B1.34B781.7M596.9M1.14B1.33B1.83B1.68B
Operating CF Growth %
294.27%23.81%115.23%-5.05%-41.75%-23.64%90.67%17.1%37.61%467%
Operating CF / Revenue %
8.4%8.21%14.83%13.96%7.67%5.86%10.22%11.22%14.31%12.78%
Net Income
519.6M251M382.6M441.8M1.37B276.6M642.5M760.2M872.7M1B
Depreciation & Amortization
115.7M126.9M125.8M144.3M171.6M182M196.4M223.5M250M259.8M
Stock-Based Compensation
35.5M57.1M55.9M57.9M66.7M62.6M75.1M81.1M063.2M
Deferred Taxes
-4.2M20.4M89.5M191.6M131.7M63.8M-108.5M244.9M0117.2M
Other Non-Cash Items
-233.2M49.6M130.7M134.3M-717.4M230.2M71.6M24M298.2M45.6M
Working Capital Changes
97M151.7M628.9M372.1M-243.3M-218.3M261M-1M413M195.8M
Cash from Investing
-541.2M-2.2B-619.8M-735.2M157.6M-262.1M-637.7M-657.8M-1.46B-1.32B
Capital Expenditures
-62.1M-82.8M-110.3M-121.2M-187.4M-186.3M-202.5M-221.3M-235.5M-182.1M
Acquisitions
-129.1M-1.05B-7.6M-531.9M1.3B-67.7M-300K-17.9M-23.5M-23.5M
Purchase of Investments
-4.34B-6.32B-4.34B-2.59B-3.2B-3.2B-2.29B-2.48B-3.38B-2.44B
Sale/Maturity of Investments
4B5.34B3.88B2.45B2.5B3.23B1.89B2.07B2.17B1.94B
Other Investing
-11.4M-92.2M-44M58.5M-256.1M-39.2M-32.8M-16.5M6M-611.6M
Cash from Financing
-26.7M1.84B-179.2M-264.8M-1.09B-818.4M-403.9M-477.5M-364.2M-245.5M
Dividends Paid
-119M-148M-170M-173.3M-162.3M-150.2M-152.3M-155.9M-168.4M-127.5M
Share Repurchases
-388.9M-139.3M-271.8M-297M-839.3M-572.8M-193.1M-307.4M-303.7M-239.4M
Stock Issued
0276.4M00000000
Debt Issuance (Net)
1000K1000K1000K1000K-1000K-1000K-1000K01000K1000K
Other Financing
30.4M25M27.1M-37M0-19.5M-6.7M-14.2M-13.8M-300K
Net Change in Cash
-35.2M▲ 0%
257.2M▲ 830.7%
613.1M▲ 138.4%
361.5M▼ 41.0%
-173.8M▼ 148.1%
-518.1M▼ 198.1%
90.7M▲ 117.5%
180.3M▲ 98.8%
26.4M▼ 85.4%
164.5M▲ 0%
Exchange Rate Effect
2.3M-35M-1.3M19.5M-23.3M-34.5M-5.8M-17.1M14.5M4.7M
Cash at Beginning
1.03B996.8M1.25B1.87B2.23B2.05B1.54B1.63B1.81B0
Cash at End
996.8M1.25B1.87B2.23B2.05B1.54B1.63B1.81B1.83B0
Free Cash Flow
468.3M▲ 0%
573.9M▲ 22.5%
1.3B▲ 127.1%
1.22B▼ 6.3%
594.3M▼ 51.3%
410.6M▼ 30.9%
935.6M▲ 127.9%
1.11B▲ 18.8%
1.6B▲ 43.8%
1.5B▲ 0%
FCF Growth %
850.03%22.55%127.06%-6.32%-51.32%-30.91%127.86%18.79%43.82%-4.6%
FCF Margin %
7.42%7.17%13.67%12.7%5.83%4.03%8.4%9.36%12.47%11.4%
FCF per Share
8.479.6420.9119.329.887.517.421.1431.8429.88

AIZN Key Ratios

Assurant, Inc. 5.25% Subordinat (AIZN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio
92.96%95.83%95.23%93.98%92.43%96.57%92.75%92.19%91.51%90.58%
Medical Cost Ratio
50.87%58.04%59%61.88%59.27%23.15%22.65%23.29%22.85%22.17%
Return on Equity (ROE)
12.4%5.33%7.07%7.58%23.85%5.71%14.22%15.33%15.9%17.4%
Return on Assets (ROA)
1.69%0.69%0.9%0.99%3.47%0.83%1.93%2.21%2.45%2.83%
Equity / Assets
13.45%12.49%12.83%13.34%16.11%12.77%14.3%14.58%16.18%17.5%
Book Value / Share
77.4186.2291.1994.2590.8877.1989.4297.12116.97116.93
Debt / Equity
0.25x0.39x0.35x0.38x0.40x0.50x0.43x0.41x0.38x0.38x
Revenue Growth
-11.21%26.77%19.11%0.85%6%0.05%9.21%6.7%7.89%9.02%
Related:AIZN Dividend History·AIZN Revenue History·AIZN Price History·AIZN P/E History·AIZN Financial Ratios·AIZN Institutional Holders

AIZN SEC Filings & Documents

Assurant, Inc. 5.25% Subordinat (AIZN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 10, 2026·SEC

Material company update

Jan 28, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 19, 2026·SEC

FY 2025

Feb 20, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

AIZN Frequently Asked Questions

Assurant, Inc. 5.25% Subordinat (AIZN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Assurant, Inc. 5.25% Subordinat (AIZN) grew revenue by 7.9% over the past year. This is steady growth.

Yes, Assurant, Inc. 5.25% Subordinat (AIZN) is profitable, generating $1.00B in net income for fiscal year 2025 (6.8% net margin).

Dividend & Returns

Yes, Assurant, Inc. 5.25% Subordinat (AIZN) pays a dividend with a yield of 17.75%. This makes it attractive for income-focused investors.

Assurant, Inc. 5.25% Subordinat (AIZN) has a return on equity (ROE) of 15.9%. This is reasonable for most industries.

Industry Metrics

Assurant, Inc. 5.25% Subordinat (AIZN) has a combined ratio of 91.5%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in AIZN back in 2002?

Total return calculator · dividends reinvested · 24+ years of data

See returns →

How much would $100/month in AIZN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →